Phase 2 Parkinson's Disease Trial, Recruiting NCT07370532 Sponsor: Ihab Elsayed Hassan Condition: Parkinson's Disease
Back to Parkinsons Disease

Phase 2 Parkinson's Disease Trial, Recruiting

NCT07370532
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older.
  • Both men and women can take part.
  • You must have been diagnosed with Parkinson's Disease based on a standard medical assessment called the Unified Parkinson's Disease Rating Scale.

Who may not be able to join:

  • You cannot take part if you are currently breastfeeding.
  • You may not be able to join if you have serious liver or kidney problems.
  • People who misuse alcohol or drugs may not be eligible.
  • You cannot take part if you have a known allergy to any of the medications being used in this trial.
  • Women who are pregnant or planning to become pregnant cannot take part.
  • You may not be able to join if you are currently taking other anti-inflammatory medicines (medicines that reduce inflammation or swelling).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Ihab Elsayed Hassan
Registry
ClinicalTrials.gov
Start date
30 January 2026
Est. completion
10 November 2027

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

- Change in The Unified Parkinson's Disease Rating Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov